Clusterin Regulates Drug-Resistance in Melanoma Cells

Behrens, 2001, Downregulation of clusterin expression in testicular germ cell tumours, Pathobiology, 69, 19, 10.1159/000048753 Bettuzzi, 2002, Clusterin (SGP-2) transient overexpression decreases proliferation rate of SV40-immortalized human prostate epithelial cells by slowing down cell cycle progression, Oncogene, 21, 4328, 10.1038/sj.onc.1205594 Blaschuk, 1983, Purification and characterization of a cell-aggregating factor (Clusterin), the major glycoprotein in ram testes fluid, J Biol Chem, 258, 7714, 10.1016/S0021-9258(18)32238-5 Dumont, 2002, Overexpression of Apolipoprotein J in human fibroblasts protects against cytotoxicity and premature senescence induce by ethanol and tertbutylhydroperoxide, Cell Stress Chaperones, 7, 23, 10.1379/1466-1268(2002)007<0023:OOAJIH>2.0.CO;2 Han, 2001, Clusterin contributes to caspase-3-independent brain injury following neonatal hypoxia-ischemia, Nat Med, 7, 338, 10.1038/85487 Jansen, 2002, Antisense therapy for cancer – the time of truth, Lancet Oncol, 3, 672, 10.1016/S1470-2045(02)00903-8 Jones, 2002, Clusterin, Int J Biochem Cell Biol, 34, 427, 10.1016/S1357-2725(01)00155-8 July, 2004, Nucleotide-based therapies targeting clusterin chemosensitizes human lung adenocarcinoma cells both in vitro and in vivo, Mol Cancer Ther, 3, 223 Lecoeur, 2002, Multiparametric flow cytometric analysis of biochemical and functional events associated with apoptosis and oncosis using the 7-aminoactinomycin D assay, J Immunol Methods, 265, 81, 10.1016/S0022-1759(02)00072-8 Leskov, 2003, Synthesis and functional analyses of nuclear clusterin, a cell death protein, J Biol Chem, 278, 11590, 10.1074/jbc.M209233200 McLaughlin, 2000, Apolipoprotein J/Clusterin limits the severity of murine autoimmune myocarditis, J Clin Invest, 106, 1105, 10.1172/JCI9037 Miyake, 2001, Acquisition of resistance to Fas-mediated apoptosis by overexpression of Clusterin in human renal-cell carcinoma cells, Mol Urol, 5, 105, 10.1089/10915360152559585 Miyake, 2000, Antisense TRPM-2 oligodeoxynucleotides chemosensitize human androgen-independent PC-3 prostate cancer cells in vitro and in vivo, Clin Cancer Res, 6, 1655 Miyake, 2000, Testosterone-repressed prostate message-2 is an antiapoptotic gene involved in progression to androgen independence in prostate cancer, Cancer Res, 60, 170 Myers, 2000, Sensible use of antisense: How to use oligonucleotides as research tools, Trends Pharmacol Sci, 21, 19, 10.1016/S0165-6147(99)01420-0 Parczyk, 1994, Gp80 (Clusterin: TRPM-2) mRNA levels is enhanced in human renal clear cell carcinomas, J Cancer Res Clin Oncol, 120, 186, 10.1007/BF01202200 Pucci, 2004, Modulation of different clusterin isoforms in human colon tumorigenesis, Oncogene, 23, 2298, 10.1038/sj.onc.1207404 Redondo, 2000, Overexpression of Clusterin in Human Breast Carcinoma, Am J Pathol, 157, 393, 10.1016/S0002-9440(10)64552-X Rockmann, 2003, Drug-resistance in human melanoma: Mechanisms and therapeutic opportunities, Onkologie, 26, 581 Rosenberg, 1995, Clusterin: Physiologic and pathophysiologic considerations, Int J Biochem Cell, 27, 633, 10.1016/1357-2725(95)00027-M Serrone, 2000, Dacarbazine-based chemotherapy for metastatic melanoma: Thirty-year experience overview, J Exp Clin Cancer Res, 19, 21 Soengas, 2003, Apoptosis and melanoma chemoresistance, Oncogene, 22, 3138, 10.1038/sj.onc.1206454 Steinberg, 1997, Intracellular levels of SGP-2 (clusterin) correlate with tumor grade in prostate cancer, Clin Cancer Res, 3, 1707 Thomas-Tikhonenko, 2004, Myc-transformed epithelial cells down-regulate clusterin, which inhibits their growth in vitro and carcinogenesis in vivo, Cancer Res, 64, 3126, 10.1158/0008-5472.CAN-03-1953 Trougakos, 2002, Clusterin/apolipoprotein J in human aging and cancer, Int J Biochem Cell Biol, 34, 1430, 10.1016/S1357-2725(02)00041-9 Trougakos, 2004, Silencing expression of the clusterin/apolipoprotein j gene in human cancer cells using small interfering RNA induces spontaneous apoptosis, reduced growth ability, and cell sensitization to genotoxic and oxidative stress, Cancer Res, 64, 1834, 10.1158/0008-5472.CAN-03-2664 Tsao, 2004, Management of cutaneous melanoma, N Engl J Med, 351, 998, 10.1056/NEJMra041245 van Engeland, 1998, Annexin V affinity assay: A review on an apoptosis detection system based on phosphatidylserine exposure, Cytometry, 31, 1, 10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R Viard, 1998, Clusterin gene expression mediates resistance to apoptotic cell death induced by heat shock and oxidative stress, J Invest Dermatol, 112, 290, 10.1046/j.1523-1747.1999.00531.x Wehrli, 2001, Inhibition of post-ischemic brain injury by clusterin overexpression, Nat Med, 7, 977, 10.1038/nm0901-977 Wellmann, 2000, Detection of differentially expressed genes in lymphomas using cDNA arrays: Identification of clusterin as a new diagnostic marker for anaplastic large-cell lymphomas, Blood, 96, 398, 10.1182/blood.V96.2.398 Xiaodi, 2003, Clusterin as a biomarker in human intestinal neoplasia, Proc Natl Acad Sci USA, 100, 5555 Yang, 2000, Nuclear clusterin/XIP8, an x-ray-induced Ku70-binding protein that signals cell death, Proc Natl Acad Sci USA, 97, 5907, 10.1073/pnas.97.11.5907 Zellweger, 2000, Chemosensitization of human renal cell cancer using antisense oligonucleotides targeting the antiapoptotic gene Clusterin, Neoplasia, 3, 360, 10.1038/sj.neo.7900174 Zellweger, 2001, Antitumor activity of antisense clusterin oligonucleotides is improved in vitro and in vivo by incorporation of 2′-O-(2-methoxy)ethyl chemistry, J Pharmacol Exp Ther, 298, 934 Zhou, 2002, A novel anti-proliferative property of clusterin in prostate cancer cells, Life Sci, 22, 11, 10.1016/S0024-3205(02)02183-5